Building a better treatment model for Sjögren's syndrome
Part of Immune system & allergy clinical trials.
This study is building a new model to help doctors treat primary Sjögren's syndrome using a combination of traditional Chinese medicine and Western medicine. It may help find better ways to manage your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have primary Sjögren's syndrome, diagnosed using the 2002 or 2016 standard criteria.
- You cannot have any other connective tissue diseases (like lupus or rheumatoid arthritis).
- You cannot be pregnant or breastfeeding.
- You cannot have severe heart or blood vessel disease, liver or kidney failure, or a serious cancer.
- You must not have any other condition that the study doctors think would make it unsafe to participate (like severe memory problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding traditional Chinese medicine to standard care can help repair gland damage caused by Sjögren's syndrome. It is for people with primary Sjögren's who have a specific traditional Chinese medicine pattern called 'qi and yin deficiency'.
This study tests an investigational drug called ESG206, which targets a protein on immune cells, to see if it can safely reduce symptoms of primary Sjögren's syndrome. It is for people whose Sjögren's is not caused by another disease and who have active symptoms.
This study tests an investigational drug called RSLV-132 in women with Sjögren's disease to see if it can reduce symptoms like fatigue and dryness. You may join if you've been diagnosed in the last 30 years and have persistent symptoms.
This study tests a new drug called CM336 for people with primary Sjögren's syndrome (an autoimmune disease affecting salivary and tear glands). The drug is designed to help reduce disease activity in patients who haven't responded well to previous treatments.
This study tests an investigational drug called ICP-488 for people with primary Sjögren's syndrome (the main form, not caused by other conditions). The goal is to see if the drug can help control symptoms better than a placebo. Participants must have active disease and stable treatment.
This Phase 2 study tests how to measure changes in primary Sjögren’s syndrome symptoms and body activity. It may help researchers confirm which outcomes best reflect improvement and how different patient types respond to treatment.
Hear when a new Primary Sjögren Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.